Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 4
Submit an article Journal homepage
44
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Non-myeloablative Hematopoietic Stem Cell Transplantation for the Treatment of Adult T-cell Lymphoma in a Patient with Advanced Hepatic Impairment

Tamae Hamaki Department of Hematology, Toranomon Hospital, Tokyo, Japan
,
Masahiro Kami Department of Hematology, Toranomon Hospital, Tokyo, Japan
,
Masahiro Igarashi Department of Pharmacology, Toranomon Hospital, Tokyo, Japan
,
Eiji Kusumi Department of Hematology, Toranomon Hospital, Tokyo, Japan
,
Yasuji Arase Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan
,
Toru Ishibashi Developmental Research Laboratories, Shionogi and Co. Ltd., Osaka, Japan
,
Kenji Shimamura Developmental Research Laboratories, Shionogi and Co. Ltd., Osaka, Japan
,
Shigesaburo Miyakoshi Department of Hematology, Toranomon Hospital, Tokyo, Japan
,
Shin-ichi Morinaga Department of Hematology, Toranomon Hospital, Tokyo, Japan
,
Yoichi Takaue Department of Medical Oncology, Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
,
Masahiro Hayashi Department of Pharmacology, Toranomon Hospital, Tokyo, Japan
&
Yoshitomo Mutou Department of Hematology, Toranomon Hospital, Tokyo, Japan
 show all
Pages 703-708 | Published online: 01 Jul 2009

  • Tsukasaki, K., lkeda, S., Murata, K., Maeda, T., Alogami, S., Sohda, H., et al. (1993) "Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive aggressive T-cell leukemia/lymphoma". Leuk. Res. 17(2). 157 166.
  • Shimoyama, M. (1991) "Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaeniia-lymphoma. A report from the Lymphoma Study Group (1984-871", Br. J. Haematol. 79(3), 428-437.
  • Ulsunomiya, A., Miyazaki, Y. Takalsuka, Y., Hanada, S., Uozumi, K., Yashiki, S., et al, (2000) "Improved outcome of adult T cell Ieukeimia/lymphoma with allogeneic hematopoielic stem cell transplantation". Bone Marrow Transplant. 27(1). 15-20.
  • lde, T., Kumashiro, R., Hino, T., Murashima, S., Ogata, K., Koga, Y., et al. (2001) "Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine". Hepalol Res. 21(1), 76 -84.
  • Gluckman, K., Jolivet, L., Serobohaci, M.L., Devergie, A., Traineau, R., Bourdeau-Esperou, H., et al. (1990) "Use of prostuglandin El for prevention of liver veno-occlusive disease in lcukacmic patients treated by allogeneic bone marrow transplantation". Br. J Haemaiol. 74(3), 277- 281.
  • Cockcroft, D.W. and Gault, M.H. (1976) "Prediction of creacti clearance from serum crealinine". Nephron 16(1). 31-41.
  • Bearman, S., Appelbaum, F.R., Buckner, C., et al. (1988) "Regimen-related inxieity in patients undergoing hone marrow transplantation", J Clin. Oncol, 6, 1562 1568.
  • Kantihira, S., Atogami, S., Sohda, H., Momita, S., Yamada, Y. and Tomonaga, M. (1994) "Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia". Cancer 73 (11 ), 2753-2758.
  • Tochino, Y., Iwata, T., Takamizawa, A. and Hamajima, Y. (1971) "Studies on relationship between antitumor activity and metabolism of cyclophosphamide". Proc 3rd Symp. on Drug Metablosim and Action. 1971. Fukuoka, Japan.
  • Kemena, A., Fernandez, M., Bautnan, J., Keating, M. and Plunkelt, W. (1991) "A sensitive fluorescence assay for quantilation of fludarabine and metabolites in biological fluids". Clinn. Chin. Acta 200(2-3). 95 106.
  • Strasser, S.J. and McDonald, G.B. (1999) "Hepatitis viruses and hematopoietic cell transplantation: a guide to patient and donor management". Blood 93(4), 1127- 1136.
  • Xun, C.Q., McSweeney, P.A., Bocckh, M., Storb, R.F., Broudy. YC. and Thompson, J.A. (1999) "Successful nonmyeloablativc allogenteic hematopoietic stem cell transplant in an acute leukemia patient with chemotherapy-induced marrow aplasia and progressive pulmonary aspergillosis". Blood 94(9), 3273-3276.
  • Giralt, S., Estey, E., Albitar, M., van Besten, K., Rondon, G., Anderlini, P., et al. (1997) "Engraftment of of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy harnessing graft-versus-leukemia without myeloablative therapy". Blood 89(12), 4531-4536.
  • McSweeney, P.A., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.O., et al. (2000) "Hematopoic cell transplantai ion in older patients with hrmatologiv malignancies: replacing high-dose cytotoxic therapy with graft-versustumor effects". Blood 97(11). 3390-3400.
  • Yagci, M., Sucak, G.T. and Haznedar, R. (2000) "Hudarabine and risk of hepatitis B virus reactivation in chronic lymphocytic leukemia". Am. J. Hematol. 64(3), 233 234.
  • Silvestri, F., Ennacora, A., Speroito, A., Patriarca, E. Zaja, E. Damiani, D., et al. (2000) "Lamivudinc allows completion of chemotherapy in lymphoma patients with hepatitis B reacativation". Br. J. Haematol. 108(2). 394-396.
  • Wagner, T. and Fenneberg. K (1984) "Pharmacokinetics and bioavailability of cyclophosphamide trom formulations". Arzneimittflforschung 34(3). 313- 316.
  • Wagner, T., Heydrich, D., Jork, T. Voelcker, G. nod Hohorst, H.J. (1981) "Comparative study on human pharmacokinetics of activated ifosfamide and cyclophosphamide by a modified fluoronietric test". J Cancer Res. Clin. Oncol. 100(1 ), 95-104.
  • Juma, F.D. (1984) "Effect of liver failure on the phannaco- kineties of cyclophosphamide". Eur, J. Clin. Pharmacol, 26(5). 591-593.
  • Mahadevan, A., Kanegaonkar, R. and Hoskin, P.J. (1997) "Third space sequestration increases toxicity of fludarahine-a case report". Acta Oncol. 36(4). 441.
  • Malspeis, I., Grever, M.R., Staubus, A.E. and Young, D. (1990) "Pharmacokinetics of 2-F-ara-A (9-heta-o-arabinofuranosyl-2 fluoroadenine) in cancer patients during the phase I clinical investigation of fludarabine phosphate'. Senim. Oncol. 17(5 Suppl 8). 18-32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.